S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells

被引:62
作者
Mathisen, B
Lindstad, RI
Hansen, J
El-Gewely, SA
Maelandsmo, GM
Hovig, E
Fodstad, O
Loennechen, T
Winberg, JO [1 ]
机构
[1] Univ Tromso, Inst Med Biol, Dept Biochem, N-9037 Tromso, Norway
[2] Univ Tromso, Fac Med, Inst Pharm, Dept Pharmacol, N-9037 Tromso, Norway
[3] Norwegian Radium Hosp, Dept Tumor Biol, Oslo, Norway
关键词
inhibitors of matrix metalloproteinases; matrix metalloproteinases; metastasis; NF-kappa B; S100A4;
D O I
10.1023/B:CLIN.0000006819.21361.03
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To study the role of the metastasis associated protein S100A4, an osteosarcoma cell line ( OHS) with a high level of this protein was transfected with a vector containing a ribozyme that degrades S100A4 mRNA and, as controls, OHS cells were transfected with the vector alone. We have followed up our previous investigation (Bjornland et al. 1999) by a detailed investigation of these cell lines' synthesis of MMP and TIMP proteins at different cell densities. It is shown that the cell lines with a low S100A4 level produced a reduced amount of immunoreactive MMP-2 at cellular subconfluence, while at confluence there was no difference compared to the control cells. The cell lines with a reduced S100A4 level produced less of the activated form of MMP-2 (62-kDa) and less TIMP-1 than the corresponding control cells, independent of cell density. Isolated cell membranes from cell lines with a reduced S100A4 level contained less MT1-MMP, MMP-2 and TIMP-2 compared to the control cells. Activation of exogenously added proMMP-2 was less effective with the former membrane preparations. It appeared that the mechanism behind the S100A4 dependent activation of proMMP-2 varied with cell density, as SN50, a peptide inhibitor of NF-kappaB nuclear translocation reduced the activation of MMP-2 at low cell density, but had no effect at high cell density. Thus, one of the mechanisms by which S100A4 may exert its effect on metastasis of some tumors is by regulating the MMP-2 activity.
引用
收藏
页码:701 / 711
页数:11
相关论文
共 63 条
[41]  
2-P
[42]  
NEWBY AC, 1994, BASIC RES CARDIOL, V89, P59
[43]  
Noë V, 2001, J CELL SCI, V114, P111
[44]   A FLUORESCENT SCREENING ASSAY FOR COLLAGENASE USING COLLAGEN LABELED WITH 2-METHOXY-2,4-DIPHENYL-3(2H)-FURANONE [J].
OGRADY, RL ;
NETHERY, A ;
HUNTER, N .
ANALYTICAL BIOCHEMISTRY, 1984, 140 (02) :490-494
[45]   Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity [J].
Pei, DQ ;
Weiss, SJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (15) :9135-9140
[46]   Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-κB-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells [J].
Philip, S ;
Bulbule, A ;
Kundu, GC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (48) :44926-44935
[47]   Tissue inhibitor of metalloproteinases-1 (TIMP-1) binds to the cell surface and translocates to the nucleus of human MCF-7 breast carcinoma cells [J].
Ritter, LM ;
Garfield, SH ;
Thorgeirsson, UP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (02) :494-499
[48]   A MATRIX METALLOPROTEINASE EXPRESSED ON THE SURFACE OF INVASIVE TUMOR-CELLS [J].
SATO, H ;
TAKINO, T ;
OKADA, Y ;
CAO, J ;
SHINAGAWA, A ;
YAMAMOTO, E ;
SEIKI, M .
NATURE, 1994, 370 (6484) :61-65
[49]   Membrane-type matrix metalloproteinases [J].
Seiki, M .
APMIS, 1999, 107 (01) :137-143
[50]   Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention [J].
Stetler-Stevenson, WG .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (09) :1237-1241